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Abstract
Little research has focused on systematically integrating clinical treatment within existing drug court procedures. This 
could be particularly useful for clients with substance use disorders, who comprise those on court dockets and often have 
co-existing mental health issues. This article reports on the preliminary outcomes of integrating MISSION-Criminal Justice 
(MISSION-CJ), a co-occurring mental health and substance use wraparound intervention, within two Massachusetts drug 
courts. In this open pilot, clients completed intake and 6-month follow-up assessments. The participants were primarily 
Caucasian (86%), male (82%), had at least 2 prior arrests, and received outpatient treatment for mental health (54%), alco-
hol use (51%), or drug use (88%) prior to enrolling in MISSION-CJ. Six-month follow-up data suggested that participants 
showed statistically significant reductions in average number of nights spent in jail, alcohol use, and drug use, as well as an 
increase in full time employment.
Keywords Alternatives to incarceration · Drug courts · Co-occurring disorders treatment
Introduction
Various alternative to incarceration programs have gained 
popularity in the United States over the past several years, 
offering offenders with specific backgrounds (e.g., veterans) 
and problem areas (e.g., substance use, mental health, or a 
co-occurring disorder) a chance to address these issues in 
lieu of incarceration, while also providing society an oppor-
tunity to reduce prison overcrowding and spending (Piquero 
2010). Drug courts are a particular type of alternative to 
incarceration program that have grown dramatically over 
the past 25 years in response to the high rates of substance 
use among criminal justice involved individuals (Fox et al. 
2015). Clients enrolled in drug courts often have comorbid 
mental health problems, with reported rates of 30–40% of 
the docket (Belenko 2001). While specialized court dockets 
for individuals with co-occurring disorders courts have been 
developed to address the multifaceted needs of the clients, 
it remains more common for drug courts and mental health 
courts to be run separately, while still enrolling clients with 
a co-occurring disorder (COD) (Steadman et al. 2013).
Both drug courts and mental health courts are designed 
to link offenders to community-based mental health or sub-
stance use treatment services (Steadman et al. 2001) and 
have yielded a number of positive outcomes, including 
reductions in recidivism and substance use, and improved 
psychological functioning (Case et al. 2009; Knudsen and 
Wingenfeld 2016). Furthermore, a recent econometric 
simulation study estimating the potential cost savings sug-
gested that diverting offenders from prison to drug treatment 
resulted in a $22.5 billion benefit to society in general and 
$12.9 billion in savings to the criminal justice system (Zar-
kin et al. 2015).
Drug courts, like all specialty courts, share a number of 
common practices, including a specialized court docket with 
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regular appearances in front of a specific judge who over-
sees the drug court session, monitors participant adherence, 
receives input from probation officers, and conducts ongoing 
monitoring of client participation in drug treatment, with 
sanctions and rewards to help move the participant toward 
recovery (Brown 2010). However, to date, limited research 
has focused specifically on clinical treatment programs that 
are uniquely designed and oriented to serve drug court par-
ticipants alongside the court personnel such as probation, as 
opposed to focusing on the drug court outcomes when treat-
ment as usual is provided in the community by a provider 
who takes drug court referrals just like any other referral 
source. Of note, while not reported in the literature, anecdo-
tal observations suggest that integrating treatment providers 
within drug courts could improve outcomes by increasing 
the alignment between the treatment community and court 
case processing. This is particularly relevant for clients in 
drug courts who have co-occurring mental health problems; 
they are often more difficult to engage in care compared to 
those with only an addiction problem and require wrapa-
round support services in order to comprehensively address 
all of their treatment needs (Peters et al. 2012). Clients with 
co-occurring disorders also often have high unemploy-
ment rates and difficulty securing and sustaining employ-
ment, which further compounds their recovery difficulties 
(O’Connor et al. 2012).
Researchers have recently urged the field to develop com-
prehensive behavioral and criminal justice interventions that 
meet the complex mental health, substance use, and criminal 
justice needs of offenders, with the ultimate goal of reduc-
ing service fragmentation (Epperson et al. 2014; Wolff et al. 
2013). Maintaining Independence and Sobriety through 
Systems Integration, Outreach, and Networking-Criminal 
Justice (MISSION-CJ) is an example of such a wraparound 
intervention. MISSION-CJ is unique in that one of the core 
components is assertive community outreach along with 
attention to criminal justice outcomes, allowing providers to 
go to the drug court sessions and the community as opposed 
to traditional treatment often occurring in an office-based 
setting for individuals who are also enrolled in a drug court. 
This paper reports the results of a pilot study assessing the 
preliminary efficacy of integrating MISSION-CJ within two 
Massachusetts drug courts and the preliminary 6-month pro-
gram outcomes.
Methods
Program Description
MISSION-CJ Model Development
MISSION-CJ was adapted from our wraparound approach 
called MISSION, originally developed to help clients with 
a co-occurring mental health and substance abuse prob-
lem engage in community supports while simultaneously 
addressing some of their clinical needs, and has recently 
been included in the Substance Use and Mental Health 
Services National Registry for Evidence Based Practices 
(Smelson et  al. 2007; MISSION 2016). Our previous 
research has shown MISSION to improve mental health, 
substance use, housing, and employment outcomes for 
homeless clients as well as veterans (Smelson et al. 2012, 
2013, 2015). MISSION was recently adapted and pilot 
tested with criminal-justice involved veterans who were 
diverted from jail, but not seen in a specialty court ses-
sion (Smelson et al. 2015). The adaptations of MISSION 
for homeless clients, to MISSION-CJ for justice-involved 
clients included the integration of a criminogenic risk 
and need assessment, and was incorporated into a new 
MISSION-CJ Treatment Manual (Pinals et al. 2014) and 
Participant Workbook (Smelson et al. 2014).
MISSION-CJ Service Delivery Structure and Treatment 
Components
MISSION-CJ is delivered jointly by a case manager and 
peer support specialist, who carry caseloads of approxi-
mately 15 clients per case manager/peer support special-
ist team. This small caseload size is a deliberate program 
design made in an effort to offer intensive, community-
based support. The MISSION-CJ services are intended to 
be integrated within the specialty court docket and in par-
allel with probation. These services are generally offered 
for 12 months as part of a court-order and a term of pro-
bation. MISSION-CJ staff works closely with probation 
throughout the program duration to support the client’s 
community success and adherence to terms of probation. 
The MISSION-CJ curriculum includes approximately 
2.5 h of individual and group sessions per week for 10 
months, reduced to twice per month during months 11 and 
12. “Dosing” of MISSION-CJ programming and treatment 
referrals can be titrated depending on the risk level of the 
client with regard to recidivism. Modeled after the origi-
nal MISSION intervention for homeless clients, the same 
core treatment components were used in the MISSION-CJ 
approach (Smelson et al. 2015).
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The first core component of MISSION-CJ is Critical 
Time Intervention (CTI) case management (Susser et al. 
1997), which offers intensive community based services 
immediately upon re-entry into the community or after 
an arrest and subsequent court appearance. The goal of 
CTI is to work with the client to establish firm linkages 
with supports in the community, including service pro-
viders, given that MISSION-CJ services are time-lim-
ited. Complementary to the CTI approach is the second 
treatment component of MISSION-CJ; Dual Recovery 
Therapy (DRT) (Ziedonis and Stern 2001), with 13 ses-
sions delivered in the first 3 months of enrollment into the 
MISSION-CJ program. DRT sessions seek to raise aware-
ness of the impact of mental illness, substance use, and 
other harmful behaviors on clients’ lives, and offer tools 
to aid in recovery. Moreover, the DRT sessions focus on 
such topics as how an individual’s mental health and sub-
stance use are interrelated, how to help motivate clients 
to engage in recovery while addressing the possible varia-
tion across problem areas, and how to help clients develop 
coping skills to address their mental health and addiction 
issues and prevent future relapses. DRT booster sessions 
are conducted throughout the duration of MISSION-CJ to 
reinforce DRT topics covered in the first 13 sessions that 
the client needs to review further.
The third treatment component of MISSION-CJ is Peer 
Support (Chinman et al. 2010, 2014), delivered in conjunc-
tion with CTI and DRT. Peer Support Specialists deliver 
11 recovery oriented sessions from a frame of reference 
of someone who has “been there,” and can serve as a role 
model for others in recovery. Peer Support Specialists also 
offer clients assistance in adjusting to new routines, such as 
avoiding triggers for engaging in criminal and/or substance 
use behavior, and emphasizing the importance of engaging 
with needed treatment supports. Vocational and educational 
supports are the fourth component of MISSION-CJ and are 
offered to help clients find and maintain employment and 
achieve educational goals, thus contributing to daily living 
stability, reducing recidivism risk, and improving quality of 
life outcomes. In MISSION-CJ, the case manager and peer 
specialist teams not only link clients to existing vocational 
and educational services in the community, but also offer 
job search, placement, and coaching. All MISSION-CJ Case 
Managers and Peer Support Specialists are also cross-trained 
to deliver the fifth component of MISSION-CJ, trauma 
informed care. While MISSION-CJ is not a co-occurring 
Post Traumatic Stress Disorder and Addiction Treatment 
intervention, case managers and peer specialists are trained 
to work with clients with trauma histories in a way that is 
trauma-sensitive, as well as to assess and refer clients to 
other treatment providers who offer evidence-based treat-
ments for the management of trauma symptoms. MISSION-
CJ case managers and peer specialists also provide trauma 
informed support for those clients with sub-threshold symp-
toms or who received a previous referral. In addition to 
receiving CTI, DRT, peer support, vocational and education 
support, and trauma informed care, MISSION-CJ clients are 
also routinely linked to other community-based psychiatric 
services and psychosocial supports including medication 
management, PTSD treatment, assistance with benefits and 
entitlements, and family therapy, to name a few.
However, as noted above, the entire MISSION-CJ model 
operates in the context of the client’s level of criminal recidi-
vism risk and needs. Therefore, the sixth component, specific 
to the MISSION-CJ adaptation of the original MISSION 
model is the incorporation of the Risk-Need-Responsivity 
(RNR) framework, which posits that criminal justice agen-
cies and treatment programs should target criminogenic 
needs (Andrews et al. 1990; Andrews and Bonta 2006; Bonta 
and Andrews 2007; Taxman and Thanner 2006). Moreover, 
the RNR model of assessment and treatment has three core 
principles: Risk: the level of service should be matched to 
the participant’s level of risk to re-offend. Need: assess each 
participant’s specific “criminogenic” needs such as impul-
sivity, antisocial cognitions, lack of prosocial peer group 
engagement, and disconnection from family, to name a few, 
and build treatment around those needs. Responsivity: maxi-
mize each participant’s ability to learn from treatment by 
providing cognitive behavioral interventions and tailoring 
those interventions to the unique learning style, motivation, 
abilities, and strengths of the offender. The RNR framework 
guides MISSION-CJ staff in their initial treatment planning 
regarding the use of each MISSION-CJ treatment compo-
nent, and ongoing monitoring on their progress in addressing 
those needs. MISSION-CJ staff also ran a group for pro-
gram participants whenever space permitted inside the court 
house. As noted above, these MISSION-CJ services were 
offered for a maximum of 12 months as long as the client 
was enrolled in the drug court.
MISSION-CJ’s Role Within Drug Courts
In integrating MISSION-CJ in the two Massachusetts Drug 
Court settings in the Boston Metro Area, it was first critical 
to identify the role of the providers in the courts. This was 
done through a series of meetings with judges, probation, 
other drug court personnel, and the developers of MISSION-
CJ. Through these meetings and based on prior experience 
adapting the model for the criminal justice population, it 
was decided that MISSION-CJ case management and peer 
specialist teams would go into the courts as well as offer 
services outside of the court session. With regard to work 
within the court, MISSION-CJ staff participated in pre-court 
meetings between judges, attorneys, the court-appointed 
probation officer, and treatment providers to learn about the 
specific needs of each client, and attended each drug court 
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session. Participation in MISSION-CJ is voluntary, as is par-
ticipation in drug court. Early studies have begun to examine 
voluntariness and perceived coercion for participants in such 
programs (Trojano et al. 2017). At the same time, by agree-
ing to participate, information sharing releases are secured 
to allow case coordination across treatment and criminal jus-
tice and court personnel. This approach allows MISSION-CJ 
staff, the judge, and probation to discuss client disposition 
and to make real time changes to the treatment plan. A deci-
sion to not participate in drug court could result in having 
one’s criminal case processed in the usual pathway, which 
generally entailed incarceration. Thus, participation in the 
specialty court as a whole was viewed as an alternative to 
incarceration, and MISSION-CJ was an augmentation of 
treatment resources for participants.
Study Design
This study employed an open pilot design to examine the 
preliminary efficacy of integrating MISSION-CJ in two 
existing Massachusetts drug court programs. Clients, rep-
resented by counsel, were initially enrolled in the two Mas-
sachusetts Drug Courts. Once enrolled in the drug court, 
clients who had a co-occurring mental health and substance 
abuse problem, and appeared to meet program eligibility 
criteria below, were invited by the judge to participate in 
MISSION-CJ services. Enrollment into the MISSION-CJ 
services included (1) persons of both genders who were 
18 years of age or older and (2) were enrolled in one of 
two drug court programs; (3) met criteria for a DSM-IV-
TR Axis I psychiatric disorder, including depression, anxi-
ety, and/or a trauma-related issue; and (4) exhibited current 
substance use or dependence. Defendants were excluded if 
they: (1) had an acute severe psychiatric condition in need 
of immediate treatment or were acutely psychotic; (2) were 
affected by moderate to severe intellectual disability or cog-
nitive impairment as a result of traumatic brain injury (TBI); 
(3) were acutely suicidal; or (4) needed immediate medical 
attention related to substance use (i.e., withdrawal). These 
exclusion criteria were based on developing a target popula-
tion that was appropriate for drug court, had a co-occurring 
mental health condition, and also had the capacity to con-
sent to the treatment program. This project was built into 
services within the two drug courts, and all information and 
data collected was done as part of the treatment assessment 
upon intake. This information was then pulled from records 
as a means of examining data that was required as part of 
the services activity to ensure and review program quality 
in an ongoing manner for the program administrators and 
funders. As such, when reviewed by multiple state and uni-
versity Institutional Review Boards the data collection was 
deemed to be program evaluation, as opposed to research. 
Participants were therefore not required to provide research 
informed consent prior to their participation, but did sign a 
clinical informed consent to participate in the services and 
to have their clinical information pulled for program and 
services evaluation. Once enrolled, all offenders with a COD 
completed a comprehensive baseline intake assessment prior 
to starting services in the MISSION-CJ program and a 6 
month follow up assessment using the measures below.
Criminal Justice, Behavioral Health, and Related 
Measures
Baseline information regarding criminal justice involvement, 
alcohol and illicit drug use, and other behavioral health 
issues was derived from a collection of instruments required 
as a term of the Substance Abuse and Mental Health Ser-
vices Administration (SAMHSA) grant that funded this 
project. This included selected items from the Addiction 
Severity Index (ASI; McLellan et al. 1992), the Behavior 
and Symptom Identification Scale, and the SAMHSA Gov-
ernment Performance Act Questions (GPRA; Substance 
Abuse & Mental Health Services Administration 2006). 
Quantity, frequency, and severity of substance use were 
measured using the drug use section of the ASI (McLel-
lan et al. 1992), In addition, in compliance with national 
requirements, mental health and substance use service, treat-
ment, criminal justice involvement, and prevention data were 
collected via the GPRA data reporting system (Substance 
Abuse & Mental Health Services Administration 2006). Pre-
liminary program outcomes reported here were measured by 
changes in the aforementioned instruments from baseline to 
6 months post-treatment.
Data Analysis
To determine the symptom patterns of participants, frequen-
cies and descriptive analyses were computed for dichoto-
mous and continuous variables using SPSS Statistics 23. 
Data were analyzed using paired sample t tests for con-
tinuous measures and McNemar’s tests for dichotomous 
variables.
Results
Baseline Characteristics
Demographics
Demographic data for 86 clients enrolled in MISSION-CJ 
services are presented in Table 1. Clients (n = 86) were pre-
dominantly male (82.6%) and Caucasian (86.0%), mostly 
with a high school diploma/GED or higher (79.0%). Mean 
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Table 1  Baseline participant 
characteristics Variable n % M (SD)
Criminal justice
 Arrested at least one time 85 100.0
 Incarcerated for at least 1 month 83 97.6
 Lifetime arrests 17.79 (15.67)
 Lifetime convictions 14.76 (15.60)
 Lifetime months incarcerated 31.34 (49.83)
 Nights in jail in the last 30 days 10.71 (13.66)
 Nights in jail in the last 6 months 61.92 (50.60)
 History of arrests that led to charges
  Shoplifting/vandalism 40 47.1
  Parole/probation violation 76 89.4
  Drug charges 67 78.8
  Forgery 21 24.7
  Weapons 18 21.2
  Burglary/larceny/B&E 54 63.5
  Robbery 18 21.2
  Assault 36 42.4
  Arson 0 0.0
  Rape 0 0.0
  Homicide 0 0.0
  Prostitution 1 1.2
  Contempt of court 1 1.2
  Disorderly conduct/public intoxication 31 36.5
  Driving while intoxicated 22 25.9
  Other driving violations 39 45.9
  Two or more prior arrests 85 100.0
 Ever had a restraining order 25 29.4
Gender
 Male 71 82.6
 Female 15 17.4
Age (years) 33.64 (8.51)
Ethnicity
 African American 8 9.3
 Caucasian 74 86.0
 Hispanic 5 5.8
 Other 4 4.7
Education
 <12 years 18 20.9
 High school diploma/equivalent 42 48.8
 Post-high school 26 30.2
Employment (current)
 Employed 25 29.1
 Unemployed 61 70.9
Housing
 Shelter 0 0.0
 On street/outside 0 0.0
 Institution 31 36.0
 Housed 55 64.0
  Own/rent apartment, room, or house 4 4.7
  Someone else’s apartment, room, or house 1 1.2
  Halfway house 35 40.7
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age was 33.64 years (SD = 8.51), 64.0% reported being 
housed and 70.9% were unemployed.
Criminal Justice Involvement
Clients typically had relatively lengthy histories of criminal 
justice involvement that included a broad range of severity 
of criminal charges in their histories. All had been arrested 
at least twice prior to being enrolled in drug courts, and 
had an average of 17.79 lifetime arrests (SD = 15.67). The 
average age at first arrest among the sample was 17.88 years 
(SD = 5.16). On average, clients had spent a total of 
31.34 months (SD = 49.83) incarcerated during their life-
time. Given the average age of the clients, this suggests that 
many had begun their criminal justice involvement as juve-
niles (Table 2).
Preliminary MISSION‑CJ Program Outcomes
As this was an open pilot to evaluate the preliminary effi-
cacy of integrating MISSION-CJ in a drug court setting, no 
comparison group was included. Therefore, pre-test/post-test 
outcome data were computed for 67 of the 86 clients origi-
nally enrolled, who completed MISSION-CJ services and 
the 6-month follow-up assessment. The 22% attrition rate 
at 6 months was due to participants being lost to follow-up. 
While we were unable to contact clients whom were lost to 
follow-up, and thus cannot say for sure the exact reasons, 
some potential causes included a substance use or mental 
health relapse, moving out of the area, or perhaps even 
incarceration.
Assessment of criminal justice outcomes focused pri-
marily on self-reported nights in jail. Results of two-tailed 
paired sample t tests indicated significant improvements 
Table 1  (continued) Variable n % M (SD)
  Residential treatment 13 15.1
  Other/missing 2 2.3
Service use (past month)
 Inpatient for physical complaint 3 3.5
 Outpatient for physical complaint 19 22.1
 Emergency room for physical complaint 6 7.0
 Inpatient for psychiatric complaint 1 1.2
 Outpatient for psychiatric complaint 12 14.0
 Emergency room for psychiatric complaint 0 0.0
 Inpatient for substance use 14 16.3
 Outpatient for substance use 6 7.0
 Emergency room for substance use 1 1.2
Substance use and mental health
 Years used alcohol to intoxication 11.57 (9.32)
 Ever received outpatient treatment for mental health 46 54.1
 Ever received inpatient treatment for mental health 21 24.7
 Ever received ER treatment for mental health 19 22.4
 Ever received treatment for alcohol use 43 51.2
 Ever received treatment for drug use 75 88.2
Most commonly used drugs (past month)
 Alcohol 3 3.5
 Cannabis 1 1.2
 Heroin 1 1.2
 Cocaine/crack 3 3.6
 Benzodiazepines 2 2.4
 Hallucinogens 1 1.2
 Other drugs 2 2.4
 Any illicit drug 6 7.0
Trauma
 At least one traumatic event in lifetime 43 50.0
 Experienced physical abuse 27 31.8
 Experienced sexual abuse 14 16.5
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from baseline to 6-month follow-up, with an average 
reduction from 61.18 (SD = 52.83) nights spent in jail dur-
ing the 6 months prior to baseline to 33.94 (SD = 54.72) 
nights during the first 6 months of treatment [t(66) = 3.567, 
p = 0.001].
Employment was operationalized as the percentage of 
clients employed full time and percentage of clients with 
any kind of employment. Results of McNemar’s tests on 
numbers of clients with full time employment and those with 
any employment indicated significant improvements from 
baseline to 6-month follow-up in both categories. Full time 
employment improved from 16.7 to 48.5% (p < 0.001), and 
overall employment (part time or full time) improved from 
28.8 to 60.6% during the first 6 months of the treatment 
(p < 0.001).
With regard to substance use, analyses revealed signifi-
cant reductions in the percentages of clients who reported 
alcohol (36.4–10.6%) and drug use (51.5–19.7%) during the 
first 6 months of the treatment program compared to the 6 
months prior to enrollment (p < 0.001 for alcohol; p < 0.001 
for drugs).
With regard to service utilization, clients experienced a 
slight (but not statistically significant) increase in the use 
of outpatient community mental health services beyond the 
MISSION-CJ services (13.4% pre-intervention compared 
with 20.9% at 6 months). However, McNemar’s tests showed 
a significant decrease in the percentage of patients reporting 
inpatient hospitalizations for substance use (p = 0.001), and 
a significant increase in clients reporting use of outpatient 
care for physical symptoms (p = 0.008).
Discussion
To our knowledge, this is the first effort to report on the sys-
tematic integration of a co-occurring disorder and criminal 
justice treatment in drug courts. This design is unique com-
pared to typical drug court treatment that involves the court 
making a referral to a community provider to deliver co-
occurring disorder treatment services as usual and parallel 
but not integrated with court case processing and probation. 
The MISSION-CJ intervention was able to be implemented 
and embedded within drug court and probation procedures. 
Preliminary program outcomes suggest that clients dem-
onstrated significant reductions in the number of jail days, 
decreased substance use, and increased employment, which 
we at least in part attribute to the MISSION-CJ services. 
The clients also demonstrated reduced hospitalizations and 
increased linkages to medical providers. These improve-
ments were observed despite a small sample being enrolled 
in the service across two courts, suggesting that individuals 
can achieve success in key social domains while undergo-
ing treatment using the MISSION-CJ protocol. However, 
it is also possible that clients might continue to show even 
more improvement over time given this was only a 6-month 
follow-up period.
Table 2  Preliminary outcomes
Baseline mean (SD) 6-Month mean (SD) df t
Nights in jail in last 6 months 61.18 (52.83) 33.94 (54.72) 66 0.001
Baseline % 6-Month % p
Service use
 Inpatient physical 3.0 3.0 1.000
 Inpatient mental/emotional 0 0 –
 Inpatient substance 20.9 1.5 0.001
 Outpatient physical 14.9 32.8 0.008
 Outpatient mental/emotional 13.4 20.9 0.227
 Outpatient substance 6.0 6.0 1.000
 ER physical 6.0 11.9 0.344
 ER mental/emotional 0 0 –
 ER substance 1.5 0 –
Employed full or part time 28.8 60.6 0.00002
Employed full time 16.7 48.5 0.00005
Used alcohol in last 30 days 4.5 3.0 1.000
Used alcohol in last 6 months 36.4 10.6 0.0005
Used drugs in last 30 days 7.5 4.5 0.687
Used drugs in last 6 months 51.5 19.7 0.0002
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Despite the limitations of a pre-test/post-test design, we 
believe these improvements could have been due at least in 
part to the multifactorial features of the MISSION-CJ pro-
tocol, including incorporation of the Critical Time Interven-
tion approach that assists clients in actively engaging with 
community supports (Tomita and Herman 2015; Draine and 
Herman 2007). Additionally, the gains made by this group 
in employment have likely been associated with reduced jail 
days. A number of criminological theorists take the view that 
individuals’ likelihood of offending and reoffending is sig-
nificantly reduced by access to gainful employment, which 
is also supported by research findings (Laub and Sampson 
2001; Ministry of Justice 2013). Moreover, employment 
improves individuals’ economic situations, thereby reducing 
their need to engage in illicit behavior to acquire necessities 
of life. However, we believe that the success of the program 
goes beyond just increasing rates of employment. MISSION-
CJ includes a complex array of evidence-based practices, 
which in this study, were integrated within, as opposed to 
alongside existing court procedures, in an attempt to reduce 
service fragmentation and increase communication between 
probation, the court and the client. In its overarching frame-
work, MISSION-CJ is unique in that it takes a deliberate 
and systematized approach to addressing criminogenic risk 
and needs to reduce recidivism as a recovery goal for par-
ticipants. In a previous study, we integrated MISSION-CJ 
alongside probation but separate from a specialized treat-
ment court docket, and found it to be effective for increasing 
communication between the court, probation, and providers 
(Smelson et al. 2015).
In addition to the constraints associated with a pre-
test/post-test design, which include a lack of a compari-
son group and the fact that over time, clients might have 
improved irrespective of MISSION-CJ services, other 
limitations should be noted. This study only included a 6 
month follow up period, and longer follow up data might 
have revealed a negative effect on outcomes. Although 
long-term outcomes are not fully known with this pro-
gram evaluation study, other reports have suggested that 
the first few months are a critical period for engaging cli-
ents in treatment, lending further support for our findings 
(Binswanger et al. 2007). Other limitations included that 
our service providers did not consistently have available 
space within the court to deliver MISSION-CJ services nor 
did they consistently track the contacts delivered inside 
the court setting versus in the community. However, with 
regard to implementation, MISSION-CJ staff served as 
regular members of the pre-court meeting, offering ongo-
ing collaboration to the court and probation services and 
had contacts with clients between sessions. A final limi-
tation was with regard to self-reported data, such as jail 
days and re-arrest, which are best captured in rigorous 
methodically driven studies by official record data. For 
this study, that information was not available as criminal 
justice records were kept by several separate agencies dis-
tinct from the information available to us. Nonetheless, 
self-report data is routine in program evaluation contexts 
as a means of judging the effectiveness of a service deliv-
ery model (SAMHSA 2010). Given that this was intended 
to be a pilot study of our ability to integrate MISSION-CJ 
in drug courts, additional research is needed to confirm 
the extent to which the improvements could be attrib-
uted to the MISSION-CJ services and not just time in 
the drug court. That said, assuming that MISSION-CJ is 
an augmentation strategy to make drug courts even more 
effective, future evaluations need to (a) identify factors 
associated with dropout/loss to follow-up and determine 
what possible modifications could be made to reduce 
such attrition; and (b) assess the effects of MISSION-CJ 
at 12 months and, if possible, at various points thereafter. 
Finally, there is a critical need to conduct a randomized 
controlled trial of MISSION-CJ and drug courts in gen-
eral to make the ultimate determination of its true effi-
cacy and effectiveness. We believe, however, that the data 
reported here demonstrate the feasibility of implement-
ing MISSION-CJ within a drug court protocol, and have 
observed, even with a small sample, effects sufficiently 
robust to justify further research.
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